Company intelligence / Profile preview

genXtraits

San Francisco Bay Area, CA, USA

Ownership: Private
Development stage: Other

Overview

genXtraits is a San Francisco Bay Area-based crop genomics biotech company focused on developing next-generation, climate-resilient and nutritionally enhanced crop varieties through proprietary gene editing and regulator protein activation platforms. The company is in the pre-clinical development phase, with several collaborations and licensing deals underway. No clinical trial data for human therapeutics are reported, as their focus is on crop traits and agriculture.

Therapeutic areas: EndocrinologyGastroenterologyInfectious DiseasesMetabolic DisordersOther
Modalities: Gene therapyGenome editing
Industry: Agriculture & AgTech

Beyond the preview

Go deeper on genXtraits.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on genXtraits.

Explore the full profile